GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (HKSE:01167) » Definitions » Equity-to-Asset

Jacobio Pharmaceuticals Group Co (HKSE:01167) Equity-to-Asset : 0.74 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Jacobio Pharmaceuticals Group Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Jacobio Pharmaceuticals Group Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$1,174.03 Mil. Jacobio Pharmaceuticals Group Co's Total Assets for the quarter that ended in Dec. 2023 was HK$1,597.44 Mil. Therefore, Jacobio Pharmaceuticals Group Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.74.

The historical rank and industry rank for Jacobio Pharmaceuticals Group Co's Equity-to-Asset or its related term are showing as below:

HKSE:01167' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.29   Med: 0.77   Max: 0.96
Current: 0.74

During the past 6 years, the highest Equity to Asset Ratio of Jacobio Pharmaceuticals Group Co was 0.96. The lowest was -1.29. And the median was 0.77.

HKSE:01167's Equity-to-Asset is ranked better than
58.11% of 1559 companies
in the Biotechnology industry
Industry Median: 0.67 vs HKSE:01167: 0.74

Jacobio Pharmaceuticals Group Co Equity-to-Asset Historical Data

The historical data trend for Jacobio Pharmaceuticals Group Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobio Pharmaceuticals Group Co Equity-to-Asset Chart

Jacobio Pharmaceuticals Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial -1.29 0.96 0.95 0.81 0.74

Jacobio Pharmaceuticals Group Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.95 0.95 0.81 0.79 0.74

Competitive Comparison of Jacobio Pharmaceuticals Group Co's Equity-to-Asset

For the Biotechnology subindustry, Jacobio Pharmaceuticals Group Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jacobio Pharmaceuticals Group Co's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jacobio Pharmaceuticals Group Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Jacobio Pharmaceuticals Group Co's Equity-to-Asset falls into.



Jacobio Pharmaceuticals Group Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Jacobio Pharmaceuticals Group Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=1174.031/1597.443
=0.73

Jacobio Pharmaceuticals Group Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=1174.031/1597.443
=0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jacobio Pharmaceuticals Group Co  (HKSE:01167) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Jacobio Pharmaceuticals Group Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Jacobio Pharmaceuticals Group Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Jacobio Pharmaceuticals Group Co (HKSE:01167) Business Description

Traded in Other Exchanges
Address
No. 88, Kechuang 6th Street, Building F2, Beijing Economic-Technological Development Area, Beijing, CHN
Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.
Executives
Shen Zhu 2501 Other
Treasure Partner International Limited 2501 Other
Ultimate Estate Limited 2201 Interest of corporation controlled by you
Wang Yinxiang 2501 Other
Wang Xiaojie 2307 Founder of a discretionary trust who can infl
Hu Yunyan 2501 Other
Yakovpharma Ltd 2501 Other
Willgenpharma Ltd 2501 Other
Risepharma Ltd 2101 Beneficial owner
Johwpharma Ltd 2501 Other
Hmed Ltd 2501 Other
Gloryviewpharma Ltd 2501 Other
Honourpharma Ltd 2501 Other
Blesspharma Ltd 2501 Other
Hillhouse Investment Management, Ltd. 2102 Investment manager

Jacobio Pharmaceuticals Group Co (HKSE:01167) Headlines

No Headlines